טוען...
Identification of antiviral antihistamines for COVID-19 repurposing
There is an urgent need to identify therapies that prevent SARS-CoV-2 infection and improve the outcome of COVID-19 patients. Although repurposed drugs with favorable safety profiles could have significant benefit, widely available prevention or treatment options for COVID-19 have yet to be identifi...
שמור ב:
| הוצא לאור ב: | Biochem Biophys Res Commun |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier Inc.
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7713548/ https://ncbi.nlm.nih.gov/pubmed/33309272 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbrc.2020.11.095 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|